Mercator Medical SA (MRC) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Mercator Medical SA

NEUCA SA

Why is Mercator Medical SA ?

Poor long term growth as Operating profit has grown by an annual rate -148.22% of over the last 5 years

Positive results in Sep 25

ROCE(HY) Highest at 10.45%
RAW MATERIAL COST(Y) Fallen by -5.7% (YoY)
NET PROFIT(9M) Higher at PLN 20.56 MM

With ROE of 0.56%, it has a very attractive valuation with a 0.43 Price to Book Value

Over the past year, while the stock has generated a return of -11.16%, its profits have risen by 43.8% ; the PEG ratio of the company is 1.8

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -11.16% returns in the last 1 year, the stock has also underperformed Poland WIG in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Mercator Medical SA should be less than 10%
Overall Portfolio exposure to Retailing should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Mercator Medical SA for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Mercator Medical SA

-11.16%

-0.27

21.98%

Poland WIG

27.62%

1.38

19.95%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-14.85%

EBIT Growth (5y)

-148.22%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.27

Sales to Capital Employed (avg)

0.58

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

57.64%

ROE (avg)

25.78%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.43

EV to EBIT

-8.50

EV to EBITDA

62.40

EV to Capital Employed

0.27

EV to Sales

0.33

PEG Ratio

1.77

Dividend Yield

8.87%

ROCE (Latest)

-3.22%

ROE (Latest)

0.56%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

ROCE(HY)

Highest at 10.45%

RAW MATERIAL COST(Y)

Fallen by -5.7% (YoY

NET PROFIT(9M)

Higher at PLN 20.56 MM

OPERATING PROFIT(Q)

Highest at PLN 8.23 MM

OPERATING PROFIT MARGIN(Q)

Highest at 5.66 %

PRE-TAX PROFIT(Q)

At PLN 2.2 MM has Grown at 151.14%

-7What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at PLN -49.22 MM

CASH AND EQV(HY)

Lowest at PLN 400.54 MM

DEBT-EQUITY RATIO (HY)

Highest at -20.04 %

Here's what is working for Mercator Medical SA

Net Profit

At PLN 20.56 MM has Grown at 196.14%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (PLN MM)

Operating Profit

Highest at PLN 8.23 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (PLN MM)

Operating Profit Margin

Highest at 5.66 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

At PLN 2.2 MM has Grown at 151.14%

over average net sales of the previous four periods of PLN -4.29 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (PLN MM)

Net Profit

Higher at PLN 20.56 MM

than preceding 12 month period ended Sep 2025

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (PLN MM)

Raw Material Cost

Fallen by -5.7% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at PLN 7.61 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (PLN MM)

Here's what is not working for Mercator Medical SA

Operating Cash Flow

Lowest at PLN -49.22 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (PLN MM)

Cash and Eqv

Lowest at PLN 400.54 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -20.04 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio